Thrivent Financial for Lutherans Purchases 19,248 Shares of Plexus Corp. $PLXS

Thrivent Financial for Lutherans raised its holdings in Plexus Corp. (NASDAQ:PLXS) by 6.9% during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 298,117 shares of the technology company’s stock after acquiring an additional 19,248 shares during the period. Thrivent Financial for Lutherans owned approximately 1.10% of Plexus worth $43,134,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. Salomon & Ludwin LLC purchased a new position in shares of Plexus in the third quarter worth $30,000. Huntington National Bank lifted its holdings in shares of Plexus by 41.5% in the 2nd quarter. Huntington National Bank now owns 324 shares of the technology company’s stock worth $44,000 after acquiring an additional 95 shares during the last quarter. CWM LLC increased its stake in Plexus by 65.7% in the 2nd quarter. CWM LLC now owns 537 shares of the technology company’s stock worth $73,000 after buying an additional 213 shares during the period. EverSource Wealth Advisors LLC increased its position in Plexus by 583.3% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 574 shares of the technology company’s stock valued at $78,000 after purchasing an additional 490 shares during the period. Finally, Blue Trust Inc. lifted its position in shares of Plexus by 26.8% during the second quarter. Blue Trust Inc. now owns 1,073 shares of the technology company’s stock valued at $145,000 after buying an additional 227 shares during the last quarter. Hedge funds and other institutional investors own 94.45% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have issued reports on the company. Needham & Company LLC boosted their price target on Plexus from $165.00 to $206.00 and gave the company a “buy” rating in a report on Friday. Stifel Nicolaus boosted their target price on Plexus from $150.00 to $200.00 and gave the stock a “hold” rating in a research note on Friday. Weiss Ratings reissued a “hold (c+)” rating on shares of Plexus in a report on Thursday, January 22nd. Benchmark raised their target price on shares of Plexus from $165.00 to $195.00 and gave the stock a “buy” rating in a research note on Wednesday, January 28th. Finally, Wall Street Zen lowered shares of Plexus from a “buy” rating to a “hold” rating in a research report on Saturday, November 22nd. Two analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $189.20.

Insiders Place Their Bets

In other news, COO Oliver K. Mihm sold 2,327 shares of Plexus stock in a transaction dated Tuesday, November 25th. The shares were sold at an average price of $143.18, for a total transaction of $333,179.86. Following the completion of the transaction, the chief operating officer directly owned 18,442 shares in the company, valued at $2,640,525.56. This trade represents a 11.20% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Patrick John Jermain sold 2,000 shares of Plexus stock in a transaction on Tuesday, November 11th. The stock was sold at an average price of $143.53, for a total value of $287,060.00. Following the sale, the chief financial officer owned 16,961 shares in the company, valued at $2,434,412.33. This trade represents a 10.55% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 6,174 shares of company stock worth $887,196 in the last ninety days. Insiders own 1.78% of the company’s stock.

Plexus Trading Up 2.8%

Plexus stock opened at $204.96 on Tuesday. The company has a 50 day moving average price of $161.31 and a 200 day moving average price of $146.47. The company has a debt-to-equity ratio of 0.06, a quick ratio of 0.75 and a current ratio of 1.59. Plexus Corp. has a 52 week low of $103.43 and a 52 week high of $208.36. The firm has a market capitalization of $5.48 billion, a price-to-earnings ratio of 31.88 and a beta of 0.81.

Plexus (NASDAQ:PLXS) last issued its quarterly earnings results on Wednesday, January 28th. The technology company reported $1.78 EPS for the quarter, topping analysts’ consensus estimates of $1.77 by $0.01. The company had revenue of $1.07 billion during the quarter, compared to analyst estimates of $1.07 billion. Plexus had a return on equity of 12.39% and a net margin of 4.28%.The company’s quarterly revenue was up 9.6% compared to the same quarter last year. During the same period in the previous year, the company earned $1.73 earnings per share. Plexus has set its Q2 2026 guidance at 1.800-1.950 EPS. Research analysts forecast that Plexus Corp. will post 5.9 EPS for the current year.

Plexus Profile

Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.

Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.